India Hereditary Angioedema Market (2025-2031) | Trends, Competitive Landscape, Value, Outlook, Companies, Share, Industry, Segmentation, Forecast, Growth, Analysis, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F

3.3 India Hereditary Angioedema Market - Industry Life Cycle

3.4 India Hereditary Angioedema Market - Porter's Five Forces

3.5 India Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 India Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 India Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about hereditary angioedema (HAE) among healthcare professionals and patients

4.2.2 Advances in medical research leading to better understanding and treatment options for HAE

4.2.3 Rising healthcare expenditure and improving access to specialized treatments in India

4.3 Market Restraints

4.3.1 Limited availability and affordability of HAE-specific treatments in the Indian market

4.3.2 Lack of standardized diagnostic criteria for HAE leading to underdiagnosis and misdiagnosis

6.1 India Hereditary Angioedema Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 India Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 India Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F

6.1.4 India Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F

6.1.5 India Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F

6.1.6 India Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Hereditary Angioedema Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 India Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 India Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F

6.2.4 India Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F

6.3 India Hereditary Angioedema Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 India Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 India Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 India Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Hereditary Angioedema Market Export to Major Countries

7.2 India Hereditary Angioedema Market Imports from Major Countries

8.1 Number of HAE awareness campaigns conducted annually

8.2 Percentage increase in the adoption of novel HAE therapies in India

8.3 Average time taken for HAE diagnosis in India

9.1 India Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 India Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 India Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 India Hereditary Angioedema Market Revenue Share, By Companies, 2024

10.2 India Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters